These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26452923)

  • 1. New capillary gel electrophoresis method for fast and accurate identification and quantification of multiple viral proteins in influenza vaccines.
    van Tricht E; Geurink L; Pajic B; Nijenhuis J; Backus H; Germano M; Somsen GW; Sänger-van de Griend CE
    Talanta; 2015 Nov; 144():1030-5. PubMed ID: 26452923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B; Wang J; Gravel C; Allen C; Walsh M; Rinfret A; Li X; Girard M
    Vaccine; 2011 Apr; 29(18):3377-89. PubMed ID: 21397719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production.
    Schwarzer J; Rapp E; Reichl U
    Electrophoresis; 2008 Nov; 29(20):4203-14. PubMed ID: 18925582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
    Kapteyn JC; Saidi MD; Dijkstra R; Kars C; Tjon JC; Weverling GJ; de Vocht ML; Kompier R; van Montfort BA; Guichoux JY; Goudsmit J; Lagerwerf FM
    Vaccine; 2006 Apr; 24(16):3137-44. PubMed ID: 16490287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
    Kapteyn JC; Porre AM; de Rond EJ; Hessels WB; Tijms MA; Kessen H; Slotboom AM; Oerlemans MA; Smit D; van der Linden J; Schoen P; Thus JL
    Vaccine; 2009 Feb; 27(9):1468-77. PubMed ID: 19110022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C; Shao M; Cui X; Song Y; Li J; Yuan L; Fang H; Liang Z; Cyr TD; Li F; Li X; Wang J
    Biologicals; 2010 Mar; 38(2):284-9. PubMed ID: 20074976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC; Li C; Wang J; Girard M; Lorbetskie B; Gravel C; Farnsworth A; Li X; Smith DG; Cyr TD
    Vaccine; 2012 Jul; 30(32):4762-70. PubMed ID: 22643214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the influenza virus concentration in chromatographic vaccinal preparations].
    Katushkina NV; Kolikov VM; Vovk MP
    Vopr Virusol; 1983; 28(5):561-4. PubMed ID: 6659472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
    Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
    Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assay of influenza virus structural antigens in vaccines by rocket immunoelectrophoresis.
    Oxford JS; Schild GC; Wood JM; Newman RW; Seagroatt V
    Dev Biol Stand; 1977 Jun 1-3; 39():201-8. PubMed ID: 604098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroelution for purification of influenza A matrix protein for use in immunoassay.
    Donofrio JC; Coonrod JD; Karathanasis V; Coelingh KV
    J Virol Methods; 1986 May; 13(2):107-20. PubMed ID: 3734011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry.
    Garcia-Cañas V; Lorbetskie B; Cyr TD; Hefford MA; Smith S; Girard M
    Biologicals; 2010 Mar; 38(2):294-302. PubMed ID: 20074977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sixteen capillary electrophoresis applications for viral vaccine analysis.
    Geurink L; van Tricht E; van der Burg D; Scheppink G; Pajic B; Dudink J; Sänger-van de Griend C
    Electrophoresis; 2022 May; 43(9-10):1068-1090. PubMed ID: 34739151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL; Pirkle JL; Barr JR
    Vaccine; 2012 Mar; 30(14):2475-82. PubMed ID: 22197963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel assay for influenza virus quantification using surface plasmon resonance.
    Nilsson CE; Abbas S; Bennemo M; Larsson A; Hämäläinen MD; Frostell-Karlsson A
    Vaccine; 2010 Jan; 28(3):759-66. PubMed ID: 19857452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
    Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
    Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process and product monitoring of recombinant DNA-derived biopharmaceuticals with high-performance capillary electrophoresis.
    Sunday BR; Sydor W; Guariglia LM; Obara J; Mengisen R
    J Capill Electrophor Microchip Technol; 2003; 8(5-6):87-99. PubMed ID: 15369173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-precision quantitation of a tuberculosis vaccine antigen with capillary-gel electrophoresis using an injection standard.
    Shala-Lawrence A; Beheshti S; Newman E; Tang M; Krylova SM; Leach M; Carpick B; Krylov SN
    Talanta; 2017 Dec; 175():273-279. PubMed ID: 28841990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the glycoproteins of vaccinal strains of the influenza viruses solubilized by octyl-beta-D-glucopyranoside].
    Mel'nikov SK; Busygina OG; Shekut'eva NA; Reĭngol'd VN; Chumakov MP
    Vopr Virusol; 1985; 30(2):153-8. PubMed ID: 4002689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
    Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.